LncTx: A network-based method to repurpose drugs acting on the survival-related lncRNAs in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncTx: A network-based method to repurpose drugs acting on the survival-related lncRNAs in lung cancer

Published:2021 Issue: Volume:19 Page:3990-4002
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Li Albert,Huang Hsuan-Ting,Huang Hsuan-Cheng,Juan Hsueh-Fen

Funder

Taiwan Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference90 articles.

1. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin Proc,2019

2. Precision diagnosis and treatment for advanced non-small-cell lung cancer;Longo;N Engl J Med,2017

3. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A Review;Arbour;JAMA,2019

4. Changes in lung cancer treatment as a result of the coronavirus Disease 2019 Pandemic;Elkrief;JAMA Oncol,2020

5. Lung cancer: Current therapies and new targeted treatments;Hirsch;Lancet,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AI/ML and drug repurposing in lung cancer: State of the art and potential roles for retinoids;Artificial Intelligence for Medicine;2024

2. A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer;Computational and Structural Biotechnology Journal;2023

3. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications;International Journal of Molecular Sciences;2022-09-08

4. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis;Scientific Reports;2022-06-08

5. A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis;Pharmaceutics;2022-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3